ATE218857T1 - Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen - Google Patents
Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungenInfo
- Publication number
- ATE218857T1 ATE218857T1 AT96913852T AT96913852T ATE218857T1 AT E218857 T1 ATE218857 T1 AT E218857T1 AT 96913852 T AT96913852 T AT 96913852T AT 96913852 T AT96913852 T AT 96913852T AT E218857 T1 ATE218857 T1 AT E218857T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- mania
- gabapentin
- derivatives
- bipolar disorder
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 4
- 208000020925 Bipolar disease Diseases 0.000 title abstract 2
- 229960002870 gabapentin Drugs 0.000 title abstract 2
- 206010026749 Mania Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Beans For Foods Or Fodder (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/440,570 US5510381A (en) | 1995-05-15 | 1995-05-15 | Method of treatment of mania and bipolar disorder |
| PCT/US1996/005898 WO1996036328A1 (en) | 1995-05-15 | 1996-04-26 | A method of treatment of mania and bipolar disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218857T1 true ATE218857T1 (de) | 2002-06-15 |
Family
ID=23749281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96913852T ATE218857T1 (de) | 1995-05-15 | 1996-04-26 | Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5510381A (de) |
| EP (1) | EP0825857B1 (de) |
| JP (1) | JPH11505244A (de) |
| AT (1) | ATE218857T1 (de) |
| AU (1) | AU702435B2 (de) |
| CA (1) | CA2215923C (de) |
| CZ (1) | CZ288072B6 (de) |
| DE (1) | DE69621799T2 (de) |
| DK (1) | DK0825857T3 (de) |
| EE (1) | EE03420B1 (de) |
| ES (1) | ES2177783T3 (de) |
| GE (1) | GEP20002014B (de) |
| HU (1) | HUP9802087A3 (de) |
| NO (1) | NO315967B1 (de) |
| NZ (1) | NZ307366A (de) |
| PT (1) | PT825857E (de) |
| SK (1) | SK281982B6 (de) |
| WO (1) | WO1996036328A1 (de) |
| ZA (1) | ZA963826B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372792B1 (en) | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
| KR100491282B1 (ko) | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | 통증 치료용 이소부틸가바 및 그의 유도체 |
| WO1999018063A2 (en) | 1997-10-07 | 1999-04-15 | Warner-Lambert Company | Process for preparing a cyclic amino acid anticonvulsant compound |
| DE69834204T2 (de) | 1997-10-27 | 2007-03-29 | Warner-Lambert Co. Llc | Zyklische aminosäuren und deren derivate als arzneimittel |
| BR9910494B1 (pt) * | 1998-05-15 | 2011-11-01 | composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo. | |
| HU228771B1 (en) | 1998-05-15 | 2013-05-28 | Warner Lambert Co | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| WO1999061424A1 (en) | 1998-05-26 | 1999-12-02 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| JP2002520277A (ja) * | 1998-07-09 | 2002-07-09 | ワーナー−ランバート・カンパニー | 不眠症を治療する方法 |
| DK1121114T3 (da) * | 1998-10-16 | 2007-04-10 | Warner Lambert Co | Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser |
| PT1187832E (pt) | 1999-06-02 | 2003-03-31 | Warner Lambert Co | Amino heterociclos uteis como agentes farmaceuticos |
| AP2002002501A0 (en) * | 1999-10-07 | 2002-06-30 | Warner Lambert Co | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. |
| KR100667721B1 (ko) * | 2000-06-16 | 2007-01-15 | 테바 파마슈티컬 인더스트리즈 리미티드 | 제어 범위 내의 ｐｈ를 갖는 안정한 가바펜틴 |
| MXPA02010668A (es) * | 2000-06-26 | 2003-03-10 | Warner Lambert Co | Analogos de gabapentina para alteraciones del sueno. |
| US20030119908A1 (en) * | 2001-12-21 | 2003-06-26 | Zambon Group S.P.A. | Stable gabapentin compositions |
| ITMI20012750A1 (it) | 2001-12-21 | 2003-06-21 | Procos Spa | Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura |
| CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| IN2012MN02923A (de) | 2010-06-01 | 2015-06-05 | Rubicon Res Private Ltd | |
| EP2923694B1 (de) | 2014-03-27 | 2018-11-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Orale flüssige pharmazeutische lösung von gabapentin |
| US11670410B1 (en) * | 2022-04-13 | 2023-06-06 | Green Sky Creations LLC | Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| US4355044A (en) * | 1980-12-19 | 1982-10-19 | Bernardo Heller | D-Phenylalanine treatment |
| US5084479A (en) * | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
| US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| US5025035A (en) * | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
-
1995
- 1995-05-15 US US08/440,570 patent/US5510381A/en not_active Expired - Fee Related
-
1996
- 1996-04-26 AT AT96913852T patent/ATE218857T1/de not_active IP Right Cessation
- 1996-04-26 CA CA002215923A patent/CA2215923C/en not_active Expired - Fee Related
- 1996-04-26 EP EP96913852A patent/EP0825857B1/de not_active Expired - Lifetime
- 1996-04-26 EE EE9700302A patent/EE03420B1/xx not_active IP Right Cessation
- 1996-04-26 GE GEAP19964027A patent/GEP20002014B/en unknown
- 1996-04-26 DE DE69621799T patent/DE69621799T2/de not_active Expired - Fee Related
- 1996-04-26 HU HU9802087A patent/HUP9802087A3/hu unknown
- 1996-04-26 NZ NZ307366A patent/NZ307366A/en unknown
- 1996-04-26 SK SK1528-97A patent/SK281982B6/sk unknown
- 1996-04-26 ES ES96913852T patent/ES2177783T3/es not_active Expired - Lifetime
- 1996-04-26 CZ CZ19973558A patent/CZ288072B6/cs not_active IP Right Cessation
- 1996-04-26 WO PCT/US1996/005898 patent/WO1996036328A1/en not_active Ceased
- 1996-04-26 AU AU56689/96A patent/AU702435B2/en not_active Ceased
- 1996-04-26 DK DK96913852T patent/DK0825857T3/da active
- 1996-04-26 JP JP8534854A patent/JPH11505244A/ja not_active Ceased
- 1996-04-26 PT PT96913852T patent/PT825857E/pt unknown
- 1996-05-14 ZA ZA963826A patent/ZA963826B/xx unknown
-
1997
- 1997-11-14 NO NO19975234A patent/NO315967B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK152897A3 (en) | 1999-05-07 |
| EE9700302A (et) | 1998-06-15 |
| CZ288072B6 (cs) | 2001-04-11 |
| HUP9802087A3 (en) | 1999-08-30 |
| JPH11505244A (ja) | 1999-05-18 |
| ZA963826B (en) | 1996-11-21 |
| CA2215923A1 (en) | 1996-11-21 |
| NZ307366A (en) | 1999-10-28 |
| MX9707269A (es) | 1997-11-29 |
| CZ355897A3 (cs) | 1998-02-18 |
| DE69621799D1 (de) | 2002-07-18 |
| EE03420B1 (et) | 2001-06-15 |
| AU702435B2 (en) | 1999-02-18 |
| HUP9802087A2 (hu) | 1998-12-28 |
| DE69621799T2 (de) | 2003-01-02 |
| GEP20002014B (en) | 2000-04-10 |
| CA2215923C (en) | 2001-10-09 |
| US5510381A (en) | 1996-04-23 |
| NO975234D0 (no) | 1997-11-14 |
| WO1996036328A1 (en) | 1996-11-21 |
| NO975234L (no) | 1997-11-14 |
| ES2177783T3 (es) | 2002-12-16 |
| NO315967B1 (no) | 2003-11-24 |
| EP0825857A1 (de) | 1998-03-04 |
| EP0825857B1 (de) | 2002-06-12 |
| PT825857E (pt) | 2002-11-29 |
| SK281982B6 (sk) | 2001-09-11 |
| DK0825857T3 (da) | 2002-09-30 |
| AU5668996A (en) | 1996-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE218857T1 (de) | Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen | |
| CY1106020T1 (el) | Χρηση αναλογων caba για την βιομηχανικη κατασκευη ενος φαρμακου για την θepαπεια μανιας και διπολικων διαταραχων | |
| DE69631157D1 (de) | Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes | |
| ATE142877T1 (de) | Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie | |
| DE60032795D1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| DE69331605D1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| DE69813839D1 (de) | Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz | |
| ATE227127T1 (de) | Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes | |
| DE69635708D1 (de) | Tetrandrin zur behandlung von augenentzündungen | |
| ATE275966T1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
| TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
| ATE119770T1 (de) | Verwendung von acetyl l-carnitin zur therapeutischen behandlung von coma. | |
| UA27713C2 (uk) | Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі | |
| DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| BR0014372A (pt) | Derivados de 5-hidroxissapogenina com atividade antidemência | |
| BG50159A3 (bg) | Метод за получаване на производни на пиранобензоксадиазол | |
| RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
| DE69309790D1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-Furyl)-3-Derivate und pharmazeutische Präparate davon, zur Behandlung von Kardiovaskulär-Erkrankungen | |
| DE69619051D1 (de) | Behandlung von Füllstoffen mit Oxasilacycloalkanen | |
| DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| ATE297749T1 (de) | Verwendung von peptidischen bradykinin- antagonisten zur herstellung von arzneimitteln | |
| KR960003718A (ko) | 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 | |
| DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |